Cesar Moris2014-10-30 Profesor CardiologíaDirector Departamento del CorazónHospital Universitario Central de AsturiasUniversidad de OviedoOVIEDO — ESPAÑA
CoreValve for High Risk and Extreme Risk Patients; The US Pivotal Trials
Eduardo de Marchena2014-10-30 M.D., F.A.C.C., F.A.C.P., F.S.C.A.I.Professor of Medicine & SurgeryAssociate Dean for International MedicineDirector of Interventional CardiologyUniversity of Miami Miller School of Medicine
Cómo realizar un caso exitoso de TAVI. Tips and Tricks
Cesar Moris2014-10-30 Profesor CardiologíaDirector Departamento del CorazónHospital Universitario Central de AsturiasUniversidad de OviedoOVIEDO — ESPAÑA
Insuficiencia Aórtica post TAVI
Cesar Moris2014-10-30 Profesor CardiologíaDirector Departamento del CorazónHospital Universitario Central de AsturiasUniversidad de OviedoOVIEDO — ESPAÑA
Evaluation and Management of Asymptomatic Aortic Stenosis
Augusto Pichard2014-08-08 Director Innovation and Structural Heart Disease, Vice Chair, Medstar Heart Institute, Medstar Washington Hospital Center. Professor of Medicine (Cardiology),Georgetown University Medical School.Washington, DC
Hay Lugar Aun Para los Inhibidores GPIIbIIIa?
Pedro Ureña Velásquez2014-08-08 FACC FSCAI FACCPDirector Medicina Cardiovascular Asociada
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Igor F. Palacios2014-08-08 Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School
Below the Knee Interventions and Angiosome Concept
Luis A Guzman2014-08-08 Director, Cardiovascular Cath LabUniversity of Florida-Jacksonville
TAVI: Present and Future Perspective
Igor F. Palacios2014-08-08 Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School
Percutaneous Treatment of Mitral Regurgitation
Igor F. Palacios2014-08-08 Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School